Pasithea Therapeutics (KTTA) Stock Chart & Stock Price History $3.10 -0.08 (-2.52%) (As of 11/22/2024 ET) Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends Pasithea Therapeutics Stock Price Performance 5 Day Performance-1.59%1 Month Performance-23.27%3 Month Performance-33.33%6 Month Performance-51.56%Year-To-Date Performance-58.11%1 Year Performance-49.90% Receive KTTA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Pasithea Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address Buffett Dumps $982 Million in BofA Stock—What Does He Know? (Ad)Buffett's been eerily quiet about his reasons, but his actions speak volumes. When someone with his track record starts pulling out of the market, it's time to pay attention.Get your FREE, no-obligation Wealth Protection Guide now KTTA Stock Chart for Sunday, November, 24, 2024 KTTA Chart by TradingView Pasithea Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization11/22/2024$3.18$3.10-2.52%$3.30$3.0817,499 shs$3.94 million11/21/2024$3.19$3.18-0.31%$3.32$3.0645,711 shs$4.04 million11/20/2024$3.15$3.19+1.27%$3.37$2.92745,448 shs$4.04 million11/19/2024$3.20$3.15-1.56%$3.22$3.0615,121 shs$4 million11/18/2024$3.38$3.20-5.33%$3.38$3.1717,851 shs$4.06 million11/15/2024$3.30$3.38+2.42%$3.42$3.1923,741 shs$3.52 million Get the Latest News and Ratings for KTTA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Pasithea Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/14/2024$3.42$3.30-3.51%$3.45$3.308,157 shs$3.43 million11/13/2024$3.36$3.42+1.79%$3.42$3.2524,503 shs$3.56 million11/12/2024$3.30$3.36+1.82%$3.53$3.2015,228 shs$3.51 million11/11/2024$3.31$3.30-0.30%$3.70$3.2638,629 shs$3.45 million11/08/2024$3.64$3.31-9.07%$3.60$3.2047,380 shs$3.46 million11/07/2024$3.70$3.64-1.62%$3.83$3.458,648 shs$3.79 million11/06/2024$3.82$3.70-3.14%$3.87$3.5030,380 shs$3.85 million11/05/2024$3.62$3.82+5.52%$4.35$3.57134,889 shs$3.97 million11/04/2024$3.80$3.62-4.74%$3.77$3.4123,935 shs$3.78 million11/01/2024$3.80$3.80$3.80$3.6321,327 shs$3.95 million10/31/2024$3.95$3.80-3.80%$4.01$3.6614,436 shs$3.97 million10/30/2024$3.92$3.95+0.77%$4.05$3.7013,329 shs$4.12 million10/29/2024$3.69$3.92+6.23%$4.05$3.6816,049 shs$4.09 million10/28/2024$3.70$3.69-0.27%$3.99$3.6950,439 shs$3.85 million10/25/2024$4.04$3.70-8.42%$4.05$3.4035,040 shs$3.85 million10/24/2024$4.16$4.04-2.88%$4.26$3.8531,137 shs$4.21 million10/23/2024$4.23$4.16-1.65%$4.32$4.1516,894 shs$4.34 million Related Companies Vaccinex Stock Price Chart TransCode Therapeutics Stock Price Chart Aprea Therapeutics Stock Price Chart Mannatech Stock Price Chart Minerva Neurosciences Stock Price Chart TherapeuticsMD Stock Price Chart Bright Green Stock Price Chart Akari Therapeutics Stock Price Chart IN8bio Stock Price Chart NRx Pharmaceuticals Stock Price Chart Receive KTTA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Pasithea Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:KTTA) was last updated on 11/24/2024 by MarketBeat.com Staff From Our PartnersNew post-election stock warning from Wall StreetIf you’re holding U.S. stocks, it may be time to brace for impact. The S&P 500 crossed 6,000 for the first ...Chaikin Analytics | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredPopular Stocks at Risk Under Trump—Are You Holding These?The Stocks Most At-Risk from Trump’s Victory Free e-book reveals sectors – and stocks within them – likely ...StockEarnings | SponsoredAre Your Retirement Savings Really Safe?What They Don’t Want You to Know About Your 401(k)The 2008-2010 crisis wiped out almost 50% of the value of retirement funds. If you knew it was coming, wouldn'...American Hartford Gold | SponsoredDonald Trump can’t save you from this crisisElon Musk: “This Is The Most Destructive Force In History” Elon Musk claims a terrifying new economic force...Wide Moat Research | SponsoredThe Biggest Post-Election Market Shift Ever?Our No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | SponsoredA “Thank You Gift” From Pres. Trump - GeniusTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax...Colonial Metals | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pasithea Therapeutics Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pasithea Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free KTTA Stock Alerts